Cutaneous Lymphoma Expertise
The team at the Stanford Multidisciplinary Cutaneous Lymphoma Clinic has achieved world-wide recognition for its success in managing patients with cutaneous lymphomas. Their experience includes the use of state-of-the-art treatments, including:
- Topical (nitrogen mustard) and systemic chemotherapy
- Biological therapies, such as interferon and Targretin
- Light therapy, such as PUVA and UVB
- Radiation therapy, including total skin electron beam therapy
See Also
Visit the Stanford Skin Cancer Program for information on Pigmented Lesion and Melanoma; Basal Cell, Squamous Cell, Merkel Cell Carcinoma; and High Risk/Transplant.
See also the Blood and Marrow Transplant Program.
Learn more about cutaneous lymphoma treatments »
Clinical Research Protocols Available to Stanford Patients
The Stanford Lymphoma Program has a wide variety of clinical research protocols available for patient management, including a variety of biological therapies such as immune stimulants, monocloncal antibodies, and vaccines. An integral part of our research is to track the long-term outcome of our patients.
Learn more about current clinical trials »
Trial Administration